Afficher la notice abrégée

dc.creatorCholi-Papadopoulou, T.en
dc.creatorKottakis, F.en
dc.creatorPapadopoulos, G.en
dc.creatorPendas, S.en
dc.date.accessioned2015-11-23T10:24:39Z
dc.date.available2015-11-23T10:24:39Z
dc.date.issued2011
dc.identifier10.3748/wjg.v17.i21.2585
dc.identifier.issn1007-9327
dc.identifier.urihttp://hdl.handle.net/11615/26649
dc.description.abstractHelicobacter pylori (H. pylon) infection is among the most common human infections and the major risk factor for peptic ulcer disease and gastric cancer. Within this work we present the implication of C-terminal region of H. pylori neutrophil activating protein in the stimulation of neutrophil activation as well as the evidence that the C-terminal region of H. pylori activating protein is indispensable for neutrophil adhesion to endothelial cells, a step necessary to H. pylori inflammation. In addition we show that arabino galactan proteins derived from chios mastic gum, the natural resin of the plant Pistacia lentiscus var Chia inhibit neutrophil activation in vitro. (C) 2011 Baishideng. All rights reserved.en
dc.sourceWorld Journal of Gastroenterologyen
dc.source.uri<Go to ISI>://WOS:000291618900001
dc.subjectHelicobacter pylori neutrophil activating proteinen
dc.subjectHelicobacter pylorien
dc.subjectPeptic ulcer diseaseen
dc.subjectGastric canceren
dc.subjectIRON-BINDING PROTEINen
dc.subjectGASTRIC EPITHELIAL-CELLSen
dc.subjectLENTISCUS-VAR. CHIAen
dc.subjectC-TERMINAL REGIONen
dc.subjectFACTOR-KAPPA-Ben
dc.subjectHP-NAPen
dc.subjectSUCCESSFUL ERADICATIONen
dc.subjectSTRESS RESISTANCEen
dc.subjectENDOTHELIAL-CELLSen
dc.subjectHIGH PREVALENCEen
dc.subjectGastroenterology & Hepatologyen
dc.titleHelicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammationen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée